Drug Shortage Report for JAMP TAMSULOSIN
| Report ID | 218723 |
| Drug Identification Number | 02352419 |
| Brand name | JAMP TAMSULOSIN |
| Common or Proper name | Tamsulosin hydrochloride |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-05 |
| Estimated end date | 2024-04-26 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-03-19 | French | Compare |
| v4 | 2024-03-19 | English | Compare |
| v3 | 2024-02-07 | French | Compare |
| v2 | 2024-02-07 | English | Compare |
| v1 | 2024-02-07 | English | Compare |
Showing 1 to 5 of 5